Quantum Biopharma (QNTM) Assets Average (2022 - 2026)
Quantum Biopharma recorded quarterly Assets Average of $13.0 million in Q1 2026, up 3.05% quarter-over-quarter from $12.7 million in Q4 2025, and down 18.46% year-over-year from $16.0 million in Q1 2025.
Quantum Biopharma's Assets Average history runs 4 years deep, the most recent figure standing at $13.0 million for Q1 2026.
- In Q1 2026, Assets Average fell 18.46% year-over-year to $13.0 million; the TTM figure through Mar 2026 stood at $13.0 million (down 18.46% YoY), while the FY2025 annual figure was $14.1 million, down 18.25% from the prior year.
- Assets Average came in at $13.0 million for Q1 2026 at Quantum Biopharma, up from $12.7 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $63.0 million in Q1 2022 to a low of $12.7 million in Q4 2025.
- A 4-year average of $31.5 million and a median of $17.1 million in 2024 frame the typical range for Assets Average.
- On a YoY basis, Assets Average climbed as much as 14.07% in 2025 and fell as far as 29.97% in 2025.
- Quantum Biopharma's Assets Average stood at $50.7 million in 2022, then sank by 64.34% to $18.1 million in 2024, then decreased by 29.97% to $12.7 million in 2025, then rose by 3.05% to $13.0 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $13.0 million, $12.7 million, and $14.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 2.30 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.04 Mn |
| Dec 31, 2025 | 12.66 Mn |
| Sep 30, 2025 | 14.73 Mn |
| Jun 30, 2025 | 15.09 Mn |
| Mar 31, 2025 | 16.00 Mn |
| Dec 31, 2024 | 18.07 Mn |
| Sep 30, 2024 | 17.14 Mn |
| Dec 31, 2022 | 50.69 Mn |
| Sep 30, 2022 | 62.96 Mn |
| Jun 30, 2022 | 62.96 Mn |
| Mar 31, 2022 | 62.96 Mn |